Go to main content
Contact us
4 FEB 2015, 08:00

Fourth quarter October-December 2014

  • Order intake was SEK 618 (374) million
  • Net sales were SEK 656 (325) million
  • EBIT was SEK 231 (42) million
  • Earnings per share was SEK 2.37 (0.35)

Full year January-December 2014

  • Order intake was SEK 2,028 (1,053) million
  • Net sales were SEK 1,475 (997) million
  • EBIT was SEK 277 (32) million
  • Earnings per share was SEK 2.72 (0.14)

The Board proposes a dividend of SEK 0.80 per share and an extraordinary dividend of SEK 3.20 per share.

The Board´s assessment is that sales in 2015 will be in the span of SEK 1,650-1,750 million.

2014 – a strong year for Mycronic
“We are proud of this past year, where the Group’s order intake and sales increased 93 and 48 percent respectively. Mycronic reported a positive EBIT and strong margins for six consecutive quarters. For the full year 2014, the EBIT margin was 19 percent. The fourth quarter contributed greatly to this result. We have also entered 2015 with a record high order backlog of SEK 702 million, where the lion’s share will be delivered during the current year,” says Lena Olving, CEO and president of Mycronic AB.

The positive trend within the electronics industry generally,  and within those parts of the industry where Mycronic operates, are contributing factors behind the year's growth. Mycronic operates within a growth industry which has been beneficial. However, the year's results are also proof that the product development plan is on the right track.

“Mycronic has a strong position today with an entirely new product program launched during the last 15 months. Together with the favorable market trend for SMT equipment, the result has been a 27 percent increase in order intake within business area SMT. At the same time, we developed, completed and delivered the first P-80 mask writer faster than expected,” continues Lena Olving.

During 2014, Mycronic received a total of eight orders for mask writers. The order intake shows significant growth, but also points to the irregularity that exists within the pattern generators market. The investments in mask writers were not solely in advanced equipment for display manufacturing, but also for equipment within four other segments. Investment requirements within the various segments vary and it is more of a coincidence that these occurred more or less simultaneously in 2014.

“We have established a product development plan that supports long-term sustainable growth for the company, with profitability in focus, and that's what we're currently executing. We are delivering new, competitive products that are in sync with customers' changing needs. That’s why it is gratifying to report such strong results for full year 2014. Additionally, cash flow is strong and that puts us in a continued good financial position, thereby allowing for further growth,” concludes Lena Olving.

Contacts at Mycronic:
Lena Olving
President and CEO
+46 8 - 638 52 00    

Per Ekstedt
+46 8 - 638 52 00

About Mycronic
Mycronic AB is a high-tech Swedish company engaged in the development, manufacturing and marketing of production equipment to the electronics industry. Mycronic headquarters is located in Täby, north of Stockholm and the Group has subsidiaries in China, France, Germany, Japan, Singapore, South Korea, Taiwan, the Netherlands, United Kingdom and the US. For more information, see our web site at www.mycronic.com.

Mycronic AB (publ) is listed on NASDAQ Stockholm, Mid Cap: MYCR.